| abstract |
Novel crystalline forms of the compound (trans-4-{4-[({5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl) acetic acid are provided, together with processes for the manufacture of such forms, pharmaceutical compositions comprising them and the use of such forms in medical treatment. |